---
id: aad-acne-2024
title: "AAD 2024 Guidelines of Care for the Management of Acne Vulgaris"
short_title: "AAD Acne 2024"

organization: American Academy of Dermatology
collaborators: null
country: US
url: https://www.aad.org/clinical-guidelines
doi: null
pmid: null
open_access: true

specialty: dermatology
guideline_type: clinical-practice
evidence_system: AAD GRADE
conditions:
  - acne vulgaris
  - comedonal acne
  - inflammatory acne
tags:
  - retinoids
  - benzoyl peroxide
  - doxycycline
  - isotretinoin
  - spironolactone

publication_date: 2024-05-01
previous_version_date: 2016-02-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 AAD clinical practice guideline on the management of acne vulgaris in adolescents and adults.

## Key Recommendations

### Classification
- **Comedonal Acne**: Non-inflammatory; open/closed comedones.
- **Inflammatory Acne**: Papules, pustules, nodules, cysts.
- Severity: Mild, moderate, severe.

### Topical Therapy (First-Line for Mild-Moderate Acne)

#### Retinoids
- **Tretinoin, Adapalene, Tazarotene, Trifarotene**: Core of acne therapy. Prevents comedones, has anti-inflammatory effect.
- Adapalene 0.1% is OTC.

#### Benzoyl Peroxide (BPO)
- Kills P. acnes, reduces resistance to antibiotics when combined.
- Use in combination with topical retinoid and/or topical antibiotic.

#### Topical Antibiotics
- **Clindamycin, Erythromycin**: Should NOT be used as monotherapy due to resistance. Always combine with BPO.

#### Fixed-Dose Combinations
- Adapalene + BPO, clindamycin + BPO, tretinoin + clindamycin.

### Systemic Therapy (Moderate-Severe or Refractory Acne)

#### Oral Antibiotics
- **Doxycycline, Minocycline, Sarecycline**: Use for limited duration (3-4 months) with topical retinoid Â± BPO.
- Avoid long-term use to reduce antibiotic resistance.

#### Hormonal Therapy (Females)
- **Combined Oral Contraceptives**: FDA-approved options for acne.
- **Spironolactone**: Off-label but widely used for hormonal acne.

#### Isotretinoin
- Highly effective for severe, nodular/cystic, or treatment-resistant acne.
- iPLEDGE program required due to teratogenicity.
- Monitor lipids, LFTs, CBC.
- Many patients achieve durable remission.

### Adjunctive Therapies
- Chemical peels, comedone extraction, intralesional corticosteroids for cysts.

### Scarring
- Early, aggressive treatment prevents scarring.
- Post-acne scarring can be addressed with lasers, microneedling, fillers, subcision.
